The adherent gastric mucus gel barrier in man and changes in peptic ulceration
- PMID: 2200418
- DOI: 10.1111/j.1365-2796.1990.tb01477.x
The adherent gastric mucus gel barrier in man and changes in peptic ulceration
Abstract
The mucus barrier is a layer of water-insoluble gel adherent to the gastroduodenal epithelium. In man most previous studies have focused on luminal mucus or histological assessment of presecreted, intracellular mucus--neither of which can be directly correlated with the protective capacity of the adherent mucus barrier. We here describe direct observation of adherent mucus thickness in man, and changes in peptic ulceration. Adherent mucus gel on human antral mucosa is a continuous homogeneous layer of variable thickness, in the range 50-450 microns (median 180 microns), comprising 67% polymeric mucin. In gastric ulcer patients, adherent antral mucus is significantly increased in thickness (median 240 microns), but is very heterogeneous and structurally a substantially weaker gel, comprising only 35% polymeric mucin. Adherent antral mucus from duodenal ulcer patients is homogeneous, significantly thinner (median 110 microns), and structurally a weaker gel, comprising 50% polymeric mucin. The adherent mucus layer from patients with gastric carcinoma resembled that from subjects with gastric ulcer in that it was very heterogeneous, of significantly increased thickness (median 240 microns) and structurally a very weak gel (23% polymeric mucin). These results are discussed in the context of gastroduodenal mucosal protection against acid and pepsin in the gastric juice.
Similar articles
-
The gastroduodenal mucus barrier and its role in protection against luminal pepsins: the effect of 16,16 dimethyl prostaglandin E2, carbopol-polyacrylate, sucralfate and bismuth subsalicylate.J Gastroenterol Hepatol. 1994;9 Suppl 1:S55-9. doi: 10.1111/j.1440-1746.1994.tb01303.x. J Gastroenterol Hepatol. 1994. PMID: 7881020
-
Misoprostol-induced increases in adherent gastric mucus thickness and luminal mucus output.Dig Dis Sci. 1986 Feb;31(2 Suppl):91S-95S. doi: 10.1007/BF01309330. Dig Dis Sci. 1986. PMID: 3080296
-
Pepsins and the mucus barrier in peptic ulcer disease.Scand J Gastroenterol Suppl. 1988;146:50-7. doi: 10.3109/00365528809099130. Scand J Gastroenterol Suppl. 1988. PMID: 3147508 Review.
-
Adherent and soluble mucus in the stomach and duodenum.Dig Dis Sci. 1985 Nov;30(11 Suppl):55S-62S. doi: 10.1007/BF01309386. Dig Dis Sci. 1985. PMID: 3932055
-
The mucus barrier. Its role in gastroduodenal mucosal protection.J Clin Gastroenterol. 1988;10 Suppl 1:S93-8. J Clin Gastroenterol. 1988. PMID: 3053885 Review.
Cited by
-
The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human.Microorganisms. 2018 Aug 2;6(3):78. doi: 10.3390/microorganisms6030078. Microorganisms. 2018. PMID: 30072673 Free PMC article. Review.
-
Preparation and characterization of novel multi-core chitosan microspheres for stomach-specific delivery of hydrophilic antibiotics.J Mater Sci Mater Med. 2012 Apr;23(4):983-90. doi: 10.1007/s10856-012-4567-9. Epub 2012 Feb 10. J Mater Sci Mater Med. 2012. PMID: 22322786
-
Local gastric and serum amoxicillin concentrations after different oral application forms.Antimicrob Agents Chemother. 1993 Jul;37(7):1506-9. doi: 10.1128/AAC.37.7.1506. Antimicrob Agents Chemother. 1993. PMID: 8363383 Free PMC article.
-
Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?Virol J. 2017 Oct 6;14(1):192. doi: 10.1186/s12985-017-0855-9. Virol J. 2017. PMID: 28985745 Free PMC article. Review.
-
Formulation and Characterization of Oral Mucoadhesive Chlorhexidine Tablets Using Cordia myxa Mucilage.Jundishapur J Nat Pharm Prod. 2012 Fall;7(4):129-33. Epub 2012 Oct 7. Jundishapur J Nat Pharm Prod. 2012. PMID: 24624170 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical